Ergoteles LLC Ovid Therapeutics Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.43 - $1.86 $108,569 - $141,216	75,923 New	75,923 $141,000
Q4 2021 Feb 14, 2022	SELL	$3.13 - $3.73 $521,670 - $621,671	-166,668 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.31 - $4.04 $101,686 - $124,112	-30,721 Reduced 15.56%	166,668 $560,000
Q2 2021 Aug 12, 2021	BUY	$3.3 - $4.49 $651,383 - $886,276	197,389 New	197,389 $772,000
Q4 2020 Feb 11, 2021	SELL	$2.28 - $6.84 $59,159 - $177,477	-25,947 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$5.39 - $8.24 $139,854 - $213,803	25,947 New	25,947 $149,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.